Factor
|
Pregnant womenb
|
---|
|
Total
|
# Tested
|
% Tested
|
p-Value
|
---|
Age Group (years)
|
15-19
|
2,955
|
22
|
0.7%
|
<0.001
|
20-29
|
30,819
|
519
|
1.7%
| |
30-39
|
40,815
|
1,022
|
2.5%
| |
40-44
|
3,184
|
105
|
3.3%
| |
Urban Residence
|
No
|
10,592
|
65
|
0.6%
|
<0.001
|
Yes
|
67,181
|
1,603
|
2.4%
| |
Region
c
|
Northeast
|
9,674
|
628
|
6.5%
|
<0.001
|
North Central
|
21,206
|
313
|
1.5%
| |
South
|
34,781
|
579
|
1.7%
| |
West
|
11,970
|
148
|
1.2%
| |
Diagnostic Code for Infectious Mononucleosis
d
|
No
|
77,729
|
1,662
|
2.1%
|
<0.001
|
Yes
|
44
|
6
|
13.6%
| |
- Note: CMV, cytomegalovirus; PCR, polymerase chain reaction; IgG, Immunoglobulin G; IgM, Immunoglobulin M; DFA, direct fluorescent testing; EIA, enzyme immunoassay; ICD-9-CM, International Classification of Diseases-9th revision, Clinical Modification.
-
aCMV-specific testing includes CMV IgG, CMV IgM, CMV DFA, CMV EIA, and CMV PCR testing.
-
bPregnant women defined as female enrollees who were 1) aged 15–44 years, 2) enrolled for the entire year in 2009, and 3) had a delivery code (defined in Appendix) between October-December 2009.
-
cExcludes those pregnant women with other or unknown information on region.
-
dA diagnosis of mononucleosis was defined by an ICD-9-CM code for infectious mononucleosis (ICD-9-CM 075).